Litcius/Paper detail

Dihydroartemisinin inhibits tumor progress via blocking ROR1-induced STAT3-activation in non-small cell lung cancer

Yanping Li, Haoyi Sun, Caihong Bai, Youfan Hu, Jingyi Tang, Yuxi Zhang, Jilan Chen, Zhanqiong Zhong, Yu‐Ping He, Kaifeng Hu, Jiahui Yang, Jiahui Yang

2024International Immunopharmacology12 citationsDOI

Topics & Concepts

DihydroartemisininSignal transductionCancer researchSTAT3Receptor tyrosine kinasePhosphorylationBiologyTyrosine kinaseROR1PharmacologyCell growthReceptorChemistryCell biologyBiochemistryImmunologyArtemisininGrowth factorPlatelet-derived growth factor receptorPlasmodium falciparumMalariaCytokine Signaling Pathways and InteractionsBioactive Compounds and Antitumor AgentsPharmacological Effects of Natural Compounds
Dihydroartemisinin inhibits tumor progress via blocking ROR1-induced STAT3-activation in non-small cell lung cancer | Litcius